These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8065607)

  • 21. What is a surrogate marker for optimal dialysis?
    Ishizaki M; Matsunaga T; Itagaki I
    Hemodial Int; 2007 Oct; 11(4):478-84. PubMed ID: 17922747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prescription of peritoneal dialysis.
    Tzamaloukas AH; Raj DS; Onime A; Servilla KS; Vanderjagt DJ; Murata GH
    Semin Dial; 2008; 21(3):250-7. PubMed ID: 18248525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [New dialysis therapy modalities: what role do they play in the hemodialysis patient's outcome?].
    Mandolfo S; Imbasciati E
    G Ital Nefrol; 2002; 19(1):22-30. PubMed ID: 12165942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Higher Kt/V is needed for adequate dialysis if the treatment time is reduced. Insights from a blood flow distribution model.
    Haraldsson B
    Nephrol Dial Transplant; 1995 Oct; 10(10):1845-51. PubMed ID: 8592592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urea modeling and Kt/V: a critical appraisal.
    Barth RH
    Kidney Int Suppl; 1993 Jun; 41():S252-60. PubMed ID: 8320932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nutritional status of twice and thrice-weekly hemodialysis patients with weekly Kt/V > 3.6.
    Supasyndh O; Satirapoj B; Seenamngoen S; Yongsiri S; Choovichian P; Vanichakarn S
    J Med Assoc Thai; 2009 May; 92(5):624-31. PubMed ID: 19459522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biocompatibility and permeability of dialyzer membranes do not affect anemia, erythropoietin dosage or mortality in japanese patients on chronic non-reuse hemodialysis: a prospective cohort study from the J-DOPPS II study.
    Yokoyama H; Kawaguchi T; Wada T; Takahashi Y; Higashi T; Yamazaki S; Fukuhara S; Akiba T; Akizawa T; Asano Y; Kurokawa K; Saito A;
    Nephron Clin Pract; 2008; 109(2):c100-8. PubMed ID: 18596379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adequacy of hemodialysis and nutrition--important determinants of morbidity and mortality.
    Lindsay RM; Heidenheim AP; Spanner E; Kortas C; Blake PG
    Kidney Int Suppl; 1994 Jan; 44():S85-91. PubMed ID: 8127040
    [No Abstract]   [Full Text] [Related]  

  • 29. Non-invasive monitoring of effective dialysis dose delivered to the haemodialysis patient.
    Petitclerc T; Béné B; Jacobs C; Jaudon MC; Goux N
    Nephrol Dial Transplant; 1995; 10(2):212-6. PubMed ID: 7753455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nutritional status as a predictor of morbidity and mortality in maintenance dialysis patients.
    Kopple JD
    ASAIO J; 1997; 43(3):246-50. PubMed ID: 9152503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Indices of adequate dialysis in patients hemodialyzed with AN 69 membrane.
    Simon P; Ang KS; Cam G; Benziane A; Bonn F
    Kidney Int Suppl; 1993 Jun; 41():S291-5. PubMed ID: 8320940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Determination of the dose of dialysis with integrated modules in the same monitor].
    Torregrosa E; Hernández-Jaras J; García-Pérez H; Pons-Prades R; Calvo-Gordo C; Ríus-Peris A; Sánchez-Canel JJ; Pin-Godos M
    Nefrologia; 2006; 26(2):246-52. PubMed ID: 16808263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Kt/V as a measure of hemodialysis adequacy].
    Kovacić V
    Lijec Vjesn; 2003; 125(7-8):188-91. PubMed ID: 14692093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Dialysis adequacy: Kt/V on its way out?].
    Mandolfo S
    G Ital Nefrol; 2011; 28(2):142-6. PubMed ID: 21488027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Dialysis adequacy: the clinical illogicality of Kt/V urea].
    Basile C
    G Ital Nefrol; 2011; 28(2):147-51. PubMed ID: 21488028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [How to estimate the dietary protein intake of a hemodialysis patient? What formulate to use in practice?].
    Canaud B; Chenine L; Henriet D; Gontiers A; Rodriguez A; Leray-Moragués H
    Nephrol Ther; 2009 Jul; 5 Suppl 5():S323-9. PubMed ID: 19761967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biocompatibility and risk of infection in haemodialysis patients.
    Himmelfarb J; Hakim RM
    Nephrol Dial Transplant; 1994; 9 Suppl 2():138-44. PubMed ID: 8065605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of urea kinetic model and haemofiltration to improve nitrogen balance in haemodialysed children.
    Giani M; Picca M; Saccaggi A; Capitanio L; Galato R; Bettinelli A; Teotino N; Ghio L; Edefonti A
    Proc Eur Dial Transplant Assoc; 1983; 20():201-6. PubMed ID: 6657656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adequacy of haemodialysis in the elderly.
    Lindsay RM; Spanner E
    Geriatr Nephrol Urol; 1997; 7(3):147-56. PubMed ID: 9493036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review: membranes for haemodialysis.
    Kerr PG; Huang L
    Nephrology (Carlton); 2010 Jun; 15(4):381-5. PubMed ID: 20609086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.